Molecular insights into the association of obesity with breast cancer risk: Relevance to xenobiotic metabolism and CpG island methylation of tumor suppressor genes

Molecular and Cellular Biochemistry

Volumn 392, Issue 1-2, 2014, Pages 273-280

  Naushad, Shaik Mohammad ^a   Hussain, Tajamul ^b   Al Attas, Omar S ^b   Prayaga, Aruna ^c   Digumarti, Raghunadha Rao ^c   Gottumukkala, Suryanarayana Raju ^c   Kutala, Vijay Kumar ^c  

^a SASTRA UNIVERSITY   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

(RalGDS AF 6) domain family member 1; BCL2 adenovirus E1B 19 kDa protein interacting protein 3; Breast cancer type 1 susceptibility protein; Catechol O methyl transferase; CpG island methylation; Cytochrome P450 1A1; Extracellular superoxide dismutase; Obesity; Ras association

Indexed keywords

BRCA1 PROTEIN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; PROTEIN BNIP3; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; XENOBIOTIC AGENT; PRIMER DNA;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA DAMAGE; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIFACTOR DIMENSIONALITY REDUCTION; MULTIPLEX POLYMERASE CHAIN REACTION; OBESITY; ONSET AGE; PHENOTYPE; POSTMENOPAUSE; PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE; XENOBIOTIC METABOLISM; BREAST TUMOR; COMPLICATION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

ADULT; BASE SEQUENCE; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; XENOBIOTICS;

EID: 84905158252     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2037-z     Document Type: Article

References (35)

1. Jovanovic J, Rønneberg JA, Tost J et al (2010) The epigenetics of breast cancer. Mol Oncol 4(3):242-254
2. Apostolou P, Fostira F (2013) Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int 2013:747318
3. Simpson E, Brown KA (2013) Obesity and breast cancer: role of inflammation and aromatase. J Mol Endocrinol 51(3):T51-T59
4. Naushad SM, Pavani A, Digumarti RR et al (2011) Epistatic interactions between loci of one-carbon metabolism modulate susceptibility to breast cancer. Mol Biol Rep 38(8):4893-4901
5. Szymczak J, Milewicz A, Thijssen JH et al (1998) Concentration of sex steroids in adipose tissue after menopause. Steroids 63(5-6):319-321 (Pubitemid 28265669)
6. Naushad SM, Reddy CA, Rupasree Y et al (2011) Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer. Cell Biochem Biophys 61(3):715-723
7. Leung T, Rajendran R, Singh S, Garva R, Krstic-Demonacos M, Demonacos C (2013) Cytochrome P450 2E1 (CYP2E1) regulates the response to oxidative stress and migration of breast cancer cells. Breast Cancer Res 15(6):R107
8. Perng W, Villamor E, Shroff MR et al (2013) Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the Multi-Ethnic Study of Atherosclerosis (MESA). Nutr Metab Cardiovasc Dis S0939-4753(13):312-318
9. Fang Q, Yin J, Li F, Zhang J, Watford M (2010) Characterization of methionine adenosyltransferase 2beta gene expression in skeletal muscle and subcutaneous adipose tissue from obese and lean pigs. Mol Biol Rep 37(5):2517-2524
10. Naushad SM, Reddy CA, Kumaraswami K et al (2014) Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem Biophys 68(2):397-406
11. Naushad SM, Prayaga A, Digumarti RR et al (2012) Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) expression is epigenetically regulated by one-carbonmetabolism in invasive duct cell carcinoma of breast. Mol Cell Biochem 361(1-2):189-195
12. Korah R, Healy JM, Kunstman JW et al (2013) Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma. Mol Cancer 12:87. doi:10.1186/1476-4598-12-87
13. Ko E, Lee BB, Kim Y et al (2013) Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Clin Cancer Res 19(5):1204-1212
14. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14(8):927-939 (Pubitemid 30253002)
15. Guo K, Searfoss G, Krolikowski D et al (2001) Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ 8(4):367-376 (Pubitemid 32409607)
16. Naushad SM, Pavani A, Rupasree Y et al (2012) Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer. Mol Carcinog 51(Suppl 1):E32-E41
17. Govindaiah V, Naushad SM, Prabhakara K, Krishna PC, Radha Rama Devi A (2009) Association of parental hyperhomocysteinemia and C677T methylene tetrahydrofolate reductase (MTHFR) polymorphism with recurrent pregnancy loss. Clin Biochem 42(4-5):380-386
18. WHO (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1-452
19. Mohammad NS, Yedluri R, Addepalli P, Gottumukkala SR, Digumarti RR, Kutala VK (2011) Aberrations in one-carbon metabolism induce oxidative DNA damage in sporadic breast cancer. Mol Cell Biochem 349(1-2):159-167
20. Taioli E, Bradlow HL, Garbers SV et al (1999) Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev 23(3):232-237 (Pubitemid 29233608)
21. Lachman HM, Morrow B, Shprintzen R et al (1996) Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67:468-472
22. Lavigne JA, Goodman JE, Fonong T et al (2001) The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res 61(20):7488-7494 (Pubitemid 32995038)
23. Karbownik-Lewinska M, Szosland J, Kokoszko-Bilska A et al (2012) Direct contribution of obesity to oxidative damage to macromolecules. Neuro Endocrinol Lett 33(4):453-461
24. Biglia N, Peano E, Sgandurra P et al (2013) Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. Gynecol Endocrinol 29(3):263-267
25. Song Q, Huang R, Li J et al (2013) The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China. PLoS One 8(8):e72175
26. Turkoz FP, Solak M, Petekkaya I et al (2013) The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. J BUON 18(2):335-341
27. Adachi T, Inoue M, Hara H et al (2004) Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 181(3):413-417 (Pubitemid 38868191)
28. Peters I, Vaske B, Albrecht K et al (2007) Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Biomarkers Prev 16(12):2526-2532 (Pubitemid 351196306)
29. Ghosh S, Lu Y, Katz A, Hu Y, Li R (2007) Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells. Am J Physiol Endocrinol Metab 292(1):E246-E252 (Pubitemid 46052947)
30. Tan EY, Campo L, Han C et al (2007) BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer. Clin Cancer Res 13(2 Pt 1):467-474 (Pubitemid 46225351)
31. Pajares B, Pollán M, Martín M et al (2013) Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis. Breast Cancer Res 15(6):R105
32. Tao MH, Marian C, Nie J et al (2011) Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study. Am J Clin Nutr 94(3):831-838
33. Howard CB, Stevens J, Izevbigie EB, Walker A, McDaniel O (2003) Time and dose-dependent modulation of phase 1 and phase 2 gene expression in response to treatment of MCF-7 cells with a natural anti-cancer agent. Cell Mol Biol (Noisy-le-grand) 49(7):1057-1065
34. Mahadevan B, Arora V, Schild LJ et al (2006) Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology. Mol Carcinog 45(2):118-125 (Pubitemid 43202585)
35. Naushad SM, Krishnaprasad C, Devi AR (2014) Adaptive developmental plasticity in methylene tetrahydrofolate reductase (MTHFR) C677T polymorphism limits its frequency in South Indians. Mol Biol Rep. doi:10.1007/s11033-014- 3163-0